Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-10 2:15 pm Sale | 2024-03-28 | 13G | Formula One Group FWONA | VANGUARD INDEX FUNDS | 863,941 3.600% | -1,919,170 (-68.96%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Formula One Group FWONA | VANGUARD INDEX FUNDS | 2,783,111 11.610% | 2,783,111 (New Position) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | 1895 Bancorp of Wisconsin, Inc. BCOW | VANGUARD INDEX FUNDS | 450,277 7.370% | 450,277 (New Position) | Filing History |
| 2022-02-10 08:32 am Sale | 2021-12-31 | 13G | Research Solutions, Inc. RSSS | VANGUARD INDEX FUNDS | 597,094 2.230% | -1,134,806 (-65.52%) | Filing History |
| 2022-02-10 08:32 am Sale | 2021-12-31 | 13G | Perma-Pipe International Holdings, Inc. PPIH | VANGUARD INDEX FUNDS | 342,184 4.240% | -129,715 (-27.49%) | Filing History |
| 2022-02-10 08:22 am Sale | 2021-12-31 | 13G | LifeVantage Corporation LFVN | VANGUARD INDEX FUNDS | 712,453 5.380% | -203,376 (-22.21%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Daré Bioscience, Inc. DARE | VANGUARD INDEX FUNDS | 254,671 3.990% | 29,641 (+13.17%) | Filing History |
| 2022-02-09 3:24 pm Sale | 2021-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD INDEX FUNDS | 402 2.420% | -343 (-46.04%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 2,643 2.950% | -171 (-6.08%) | Filing History |
| 2021-07-12 10:21 am Sale | 2021-06-30 | 13G | Grosvenor Capital Management, L.P. GCMG | VANGUARD INDEX FUNDS | 996,143 2.340% | -3,411,230 (-77.40%) | Filing History |
| 2021-07-12 10:21 am Sale | 2021-06-30 | 13G | Grosvenor Capital Management, L.P. GCMG | VANGUARD INDEX FUNDS | 845,600 1.980% | -3,561,773 (-80.81%) | Filing History |
| 2021-05-27 12:27 pm Sale | 2021-01-29 | 13G | Grosvenor Capital Management, L.P. GCMG | VANGUARD INDEX FUNDS | 4,407,373 10.800% | -427,283 (-8.84%) | Filing History |
| 2021-05-27 12:25 pm Purchase | 2020-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG | VANGUARD INDEX FUNDS | 4,834,656 11.850% | 762,819 (+18.73%) | Filing History |
| 2021-05-27 12:24 pm Purchase | 2020-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG | VANGUARD INDEX FUNDS | 4,071,837 9.980% | 4,071,837 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | Daré Bioscience, Inc. DARE | VANGUARD INDEX FUNDS | 225,030 7.110% | 225,030 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | Research Solutions, Inc. RSSS | VANGUARD INDEX FUNDS | 1,731,900 6.600% | 1,731,900 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | LifeVantage Corporation LFVN | VANGUARD INDEX FUNDS | 915,829 6.420% | 915,829 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 2,814 5.930% | 2,814 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | Perma-Pipe International Holdings, Inc. PPIH | VANGUARD INDEX FUNDS | 471,899 5.780% | 6,871 (+1.48%) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD INDEX FUNDS | 746 5.010% | 746 (New Position) | Filing History |